AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Alzamend Neuro, Inc. Director's Dealing 2021

Jun 21, 2021

35321_dirs_2021-06-21_cb1ed708-dcf8-49e0-a473-73067dc75d11.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Alzamend Neuro, Inc. (ALZN)
CIK: 0001677077
Period of Report: 2021-06-14

Reporting Person: Woo Andrew H. (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct